TREX1
TREX1 (three prime repair exonuclease 1, also DRN3 or AGS1) is the major cellular 3'-to-5' DNA exonuclease. It degrades cytosolic DNA that would otherwise trigger innate immune signalling, and so helps prevent cell-intrinsic autoimmunity. Browse Assay Genie's current range of TREX1 research reagents below, or read on for the biology behind the target.
TREX1 is the major cellular 3'-to-5' DNA exonuclease. It digests single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA) with mismatched 3' termini. It metabolises DNA fragments from endogenous retroelements, including L1, LTR and SINE elements. It also processes ssDNA species that arise from aberrant DNA replication intermediates, which prevents chronic ATM-dependent checkpoint activation. It degrades oxidised DNA only inefficiently, for example DNA damaged by antimicrobial reactive oxygen production or by UV light.
A key role of TREX1 is the clearance of DNA fragments at cytosolic micronuclei, which arise from genome instability. Its association with the endoplasmic reticulum membrane directs TREX1 to ruptured micronuclei, where it degrades the DNA. This limits CGAS activation. Undegraded fragments accumulate in the cytosol and activate cGAS-STING innate immune signalling, which leads to type I interferon production. During GZMA-mediated cell death, TREX1 works with NME1. NME1 nicks one DNA strand and TREX1 removes bases from the free 3' end. This enhances DNA damage and prevents the ends from reannealing and being repaired rapidly.
The TREX1 protein belongs to the exonuclease superfamily and the TREX family. It is found in the nucleus, the cytosol and the endoplasmic reticulum membrane. The TREX1 gene has a mouse ortholog, Trex1, and alternative splicing produces multiple transcript variants. Mutations in the gene cause Aicardi-Goutieres syndrome, chilblain lupus, Cree encephalitis and other immune system diseases. This is the origin of the alias AGS1 and the previous name Aicardi-Goutieres syndrome 1. NCBI Gene notes that the protein may also contribute to DNA repair and proofreading for DNA polymerase.
TREX1 removes cytosolic DNA that would activate cGAS-STING and type I interferon production, making it central to studies of DNA sensing.
TREX1 prevents cell-intrinsic initiation of autoimmunity, and its mutations are linked to Aicardi-Goutieres syndrome and chilblain lupus.
TREX1 is directed to ruptured micronuclei at the endoplasmic reticulum membrane, where it degrades DNA to limit CGAS activation.
TREX1 processes aberrant replication intermediates to prevent chronic ATM-dependent checkpoint activation, and acts with NME1 during GZMA-mediated cell death.
TREX1 is the major cellular 3'-to-5' DNA exonuclease. It degrades ssDNA and mismatched dsDNA, including fragments from retroelements and ruptured micronuclei. By clearing this DNA it limits cGAS-STING activation and type I interferon production, and so prevents cell-intrinsic initiation of autoimmunity.
TREX1 is also known as DRN3 and AGS1. The AGS1 symbol and the previous name Aicardi-Goutieres syndrome 1 reflect the disease caused by mutations in the gene. The HGNC name is three prime repair exonuclease 1. Alternative splicing produces multiple transcript variants.
Mutations in TREX1 cause Aicardi-Goutieres syndrome, chilblain lupus, Cree encephalitis and other immune system diseases. The mouse ortholog is Trex1. For species reactivity, check the datasheet of any product for its validated reactivity.
Pathway partners in cytosolic DNA sensing, DNA damage signalling and granzyme-mediated cell death with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NSU2; product specifications from Assay Genie datasheets.